BioSpace - Print News Article

BioMedix, Inc.'s PADnet Lab System Recognized By Frost & Sullivan For Non-Invasive PVD Product Leadership 10/19/2005 5:10:34 PM PALO ALTO, Calif.--(BUSINESS WIRE)--May 3, 2005--Frost & Sullivan recently presented BioMedix Inc. with the 2005 Product Leadership of the Year Award in the non-invasive peripheral vascular disease (PVD) detection technologies segment in recognition of BioMedix's development of the innovative PADnet Lab system and associated components. Peripheral artery disease (PAD) is a condition that restricts the flow of blood in arteries leading to peripheral organs including the arms, legs, kidneys, and stomach.

BioMedix, Inc.'s PADnet Lab System Recognized By Frost & Sullivan For Non-Invasive PVD Product Leadership
10/19/2005 5:10:34 PM

PALO ALTO, Calif.--(BUSINESS WIRE)--May 3, 2005--Frost & Sullivan recently presented BioMedix Inc. with the 2005 Product Leadership of the Year Award in the non-invasive peripheral vascular disease (PVD) detection technologies segment in recognition of BioMedix's development of the innovative PADnet Lab system and associated components. Peripheral artery disease (PAD) is a condition that restricts the flow of blood in arteries leading to peripheral organs including the arms, legs, kidneys, and stomach.